| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3918 | 2012 |
| Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection TA Wagner, S McLaughlin, K Garg, CYK Cheung, BB Larsen, S Styrchak, ... Science 345 (6196), 570-573, 2014 | 750 | 2014 |
| Natural history of neonatal herpes simplex virus infections in the acyclovir era DW Kimberlin, CY Lin, RF Jacobs, DA Powell, LM Frenkel, WC Gruber, ... Pediatrics 108 (2), 223-229, 2001 | 583 | 2001 |
| A population-based study of primary human herpesvirus 6 infection DM Zerr, AS Meier, SS Selke, LM Frenkel, ML Huang, A Wald, ... New England Journal of Medicine 352 (8), 768-776, 2005 | 544 | 2005 |
| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 450 | 2018 |
| Oral acyclovir suppression and neurodevelopment after neonatal herpes DW Kimberlin, RJ Whitley, W Wan, DA Powell, G Storch, A Ahmed, ... New England Journal of Medicine 365 (14), 1284-1292, 2011 | 330 | 2011 |
| Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus NH Tobin, GH Learn, SE Holte, Y Wang, AJ Melvin, JL McKernan, ... Journal of virology 79 (15), 9625-9634, 2005 | 275 | 2005 |
| Itraconazole treatment of phaeohyphomycosis PK Sharkey, JR Graybill, MG Rinaldi, DA Stevens, RM Tucker, JD Peterie, ... Journal of the American Academy of Dermatology 23 (3), 577-586, 1990 | 247 | 1990 |
| Treatment of cytomegalovirus retinopathy with ganciclovir GN Holland, Y Sidikaro, AE Kreiger, D Hardy, MJ Sakamoto, LM Frenkel, ... Ophthalmology 94 (7), 815-823, 1987 | 224 | 1987 |
| Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022 J Hitti, LM Frenkel, AM Stek, SA Nachman, D Baker, A Gonzalez-Garcia, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (3), 772-776, 2004 | 212 | 2004 |
| The management of pregnancies complicated by genital infections with herpes simplex virus CG Prober, L Corey, ZA Brown, PA Hensleigh, LM Frenkel, YJ Bryson, ... Clinical Infectious Diseases 15 (6), 1031-1038, 1992 | 183 | 1992 |
| Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in … PS Eastman, DE Shapiro, RW Coombs, LM Frenkel, GD McSherry, ... The Journal of infectious diseases 177 (3), 557-564, 1998 | 171 | 1998 |
| Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field IA Beck, KD Drennan, AJ Melvin, KM Mohan, AM Herz, J Alarcón, ... Journal of clinical microbiology 39 (1), 29-33, 2001 | 164 | 2001 |
| Pharmacokinetics of acyclovir in the term human pregnancy and neonate LM Frenkel, ZA Brown, YJ Bryson, L Corey, JD Unadkat, PA Hensleigh, ... American journal of obstetrics and gynecology 164 (2), 569-576, 1991 | 155 | 1991 |
| Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency EK Halvas, GM Aldrovandi, P Balfe, IA Beck, VF Boltz, JM Coffin, ... Journal of clinical microbiology 44 (7), 2612-2614, 2006 | 150 | 2006 |
| Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single-or dual-agent preexposure prophylaxis DA Lehman, JM Baeten, CO McCoy, JF Weis, D Peterson, G Mbara, ... The Journal of infectious diseases 211 (8), 1211-1218, 2015 | 148 | 2015 |
| Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind … JM Baeten, D Donnell, NR Mugo, P Ndase, KK Thomas, JD Campbell, ... The Lancet infectious diseases 14 (11), 1055-1064, 2014 | 140 | 2014 |
| Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir … S Lockman, SS Brummel, L Ziemba, L Stranix-Chibanda, K McCarthy, ... The Lancet 397 (10281), 1276-1292, 2021 | 139 | 2021 |
| Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors AJ Melvin, KM Mohan, LAM ARCUINO, RE Edelstein, LM Frenkel The Pediatric infectious disease journal 16 (10), 968-974, 1997 | 135 | 1997 |
| Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments DC Nickle, MA Jensen, D Shriner, SJ Brodie, LM Frenkel, JE Mittler, ... Journal of virology 77 (9), 5540-5546, 2003 | 133 | 2003 |
